166-180 of 778
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiersMultiple Sclerosis Explained: Understanding Its Epidemiology
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiersGeneralized Myasthenia Gravis Management: Evaluating Long-Term Effects
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiersSocial Support in Schizophrenia: The Role of Emotional Awareness and Regulation
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple SclerosisUncovering Disparities in Teleneurology Utilization Post-Pandemic
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiersGenetics and Schizophrenia: Key Ethical Considerations
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
NeuroFrontiersRecognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
- advertisement
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
NeuroFrontiersUnderstanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
On the Frontlines of Multiple SclerosisManaging MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
NeuroFrontiersGaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
NeuroFrontiersFatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
NeuroFrontiersDevelopments in Duchenne Muscular Dystrophy Care: Examining the Options
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
NeuroFrontiersCaring for Women with MS: Key Considerations for Pregnancy and Menopause
- advertisement
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
On the Frontlines of SchizophreniaSchizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
NeuroFrontiersDifferentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiersDevelopments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
